CoChat

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Irreversible cell growth arrest, a process termed cellular senescence, is emerging as an intrinsic tumor suppressive mechanism. Oncogene-induced senescence is thought to be invariably preceded by hyperproliferation, aberrant replication, and activation of a DNA damage checkpoint response (DDR), rendering therapeutic enhancement of this process unsuitable for cancer treatment. We previously demonstrated in a mouse model of prostate cancer that inactivation of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (Pten) elicits a senescence response that opposes tumorigenesis. Here, we show that Pten-loss-induced cellular senescence (PICS) represents a senescence response that is distinct from oncogene-induced senescence and can be targeted for cancer therapy. Using mouse embryonic fibroblasts, we determined that PICS occurs rapidly after Pten inactivation, in the absence of cellular proliferation and DDR. Further, we found that PICS is associated with enhanced p53 translation. Consistent with these data, we showed that in mice p53-stabilizing drugs potentiated PICS and its tumor suppressive potential. Importantly, we demonstrated that pharmacological inhibition of PTEN drives senescence and inhibits tumorigenesis in vivo in a human xenograft model of prostate cancer. Taken together, our data identify a type of cellular senescence that can be triggered in nonproliferating cells in the absence of DNA damage, which we believe will be useful for developing a "pro-senescence" approach for cancer prevention and therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci40535

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 5

  1. Teng, 1997, Cancer Res., 57, 5221
  2. Bookstein, 1993, Cancer Res., 53, 3369
  3. Chen, 2009, Sci Signal., 2, ra44
  4. Roninson, 2003, Cancer Res., 63, 2705
  5. Arava, 2003, Methods Mol Biol., 224, 79

Cited by

See all 374

Metadata

Authors
Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., Cheng, K., Varmeh, S., Kozma, S. C., Thomas, G., Rosivatz, E., Woscholski, R., Cognetti, F., Scher, H. I., & Pandolfi, P. P.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • University of Cincinnati (US)
  • Imperial College London (GB)
  • Instituto Nazionale Tumori Regina Elena (IT)
Corresponding author
Pandolfi, Pier Paolo
Venue
Journal of Clinical Investigation
Published
2010-03-01
Volume
120
Issue
3
Pages
681-693
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2005250235
Cited by
374
References
46
Citations by year
2026: 13 · 2025: 17 · 2024: 23 · 2023: 12 · 2022: 24 · 2021: 18 · 2020: 30 · 2019: 17 · 2018: 27 · 2017: 17 · 2016: 20 · 2015: 20 · 2014: 28 · 2013: 25 · 2012: 27
FWCI
23.17
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Iris (University of Trento) (submittedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
  • UCL Discovery (University College London) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • Prostate Cancer Foundation
  • American-Italian Cancer Foundation
  • Associazione Italiana di Oncologia Medica
  • National Institutes of Health
  • National Cancer Institute (R01CA137050)
  • National Institute on Minority Health and Health Disparities (R01MD004038)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
cellular senescence, PTEN inactivation, prostate cancer, tumor suppression, DNA damage response, non-proliferating cells, tumor xenografts
MeSH terms
Animals, Disease Models, Animal, DNA Damage, Embryo, Mammalian, Fibroblasts, Humans, Male, Neoplasm Transplantation, Prostatic Neoplasms, Protein Biosynthesis, Transplantation, Heterologous, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Mice, Knockout, Cell Line, Tumor, Cell Proliferation, PTEN Phosphohydrolase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.